Buy & Sell Viatris Inc (VTRS) – Viatris Inc Price Today
Key Stats
- $15.47BMarket Cap
- HealthSector
- -19.65%3M Drawdown
- $28.66BEnterprise Value
- 3.57%Dividend Yield
- 55 daysTypical Hold Time
Viatris Inc (VTRS) is currently valued at a market capitalization of $15.47B, with an enterprise value of $28.66B. Over the past 52 weeks, Viatris Inc has traded between a low of $7.26 and a high of $16.13, highlighting its annual price range. Over the past three months, Viatris Inc has recorded a drawdown of -19.65%, reflecting recent price volatility. Viatris Inc offers a dividend yield of 3.57%, with the most recent dividend of $0.12 paid on 09 Mar 26. On average, investors hold Viatris Inc for approximately 55 days, indicating typical investor behavior on the platform.
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
